Convection-enhanced delivery of nanoencapsulated gene locoregionally yielding ErbB2/Her2-specific CAR-macrophages for brainstem glioma immunotherapy

[1]  Y. Liu,et al.  Intracavity generation of glioma stem cell–specific CAR macrophages primes locoregional immunity for postoperative glioblastoma therapy , 2022, Science Translational Medicine.

[2]  Elias Sayour,et al.  CAR T Cell Locomotion in Solid Tumor Microenvironment , 2022, Cells.

[3]  Jeffrey Helgager,et al.  Diffuse Intrinsic Pontine Glioma: Molecular Landscape, Evolving Treatment Strategies and Emerging Clinical Trials , 2022, Journal of personalized medicine.

[4]  C. Pan,et al.  CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy , 2022, Journal of experimental & clinical cancer research : CR.

[5]  M. Klichinsky,et al.  Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors , 2021, Frontiers in Immunology.

[6]  Anwen Shao,et al.  Opportunities and challenges of glioma organoids , 2021, Cell communication and signaling : CCS.

[7]  T. Hyeon,et al.  Nanocomplex‐Mediated In Vivo Programming to Chimeric Antigen Receptor‐M1 Macrophages for Cancer Therapy , 2021, Advanced materials.

[8]  S. Weis,et al.  Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literature , 2021, Journal of Neurology.

[9]  S. Blond,et al.  Adult brainstem glioma presenting with isolated persistent hemifacial spasm or facial nerve palsy. , 2021, Revue neurologique.

[10]  J. Ojemann,et al.  Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis , 2021, Nature Medicine.

[11]  M. Borowiec,et al.  CAR-NK Cells in the Treatment of Solid Tumors , 2021, International journal of molecular sciences.

[12]  Jianxiang Wang,et al.  Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy , 2021, Journal of Hematology & Oncology.

[13]  Z. Duan,et al.  Targeting macrophages in cancer immunotherapy , 2021, Signal Transduction and Targeted Therapy.

[14]  K. Rezvani,et al.  Outlook for New CAR-Based Therapies with a Focus on CAR NK Cells: What Lies Beyond CAR-Engineered T Cells in the Race against Cancer. , 2020, Cancer discovery.

[15]  Nicholas R. Anderson,et al.  Macrophage-Based Approaches for Cancer Immunotherapy , 2020, Cancer Research.

[16]  M. Perrone,et al.  Diffuse Intrinsic Pontine Glioma (DIPG): breakthrough and clinical perspective. , 2020, Current medicinal chemistry.

[17]  R. McLendon,et al.  The integrated genomic and epigenomic landscape of brainstem glioma , 2020, Nature Communications.

[18]  Martha E. Zeeman,et al.  Human chimeric antigen receptor macrophages for cancer immunotherapy , 2020, Nature Biotechnology.

[19]  Li Li,et al.  Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma , 2020, Science Translational Medicine.

[20]  Jason B. White,et al.  Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses , 2020, Science Translational Medicine.

[21]  Jonathan Smith,et al.  Optimizing CAR-T Cell Manufacturing Processes during Pivotal Clinical Trials , 2019, Molecular therapy. Methods & clinical development.

[22]  Jingting Jiang,et al.  CAR-NK for tumor immunotherapy: Clinical transformation and future prospects. , 2019, Cancer letters.

[23]  M. Monje,et al.  Diffuse intrinsic pontine glioma: molecular landscape and emerging therapeutic targets. , 2019, Current opinion in oncology.

[24]  Haihua Gu,et al.  The efficacy of third generation anti‑HER2 chimeric antigen receptor T cells in combination with PD1 blockade against malignant glioblastoma cells. , 2019, Oncology reports.

[25]  T. Fry,et al.  Mechanisms of resistance to CAR T cell therapy , 2019, Nature Reviews Clinical Oncology.

[26]  H. Fine,et al.  Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma , 2019, Journal of immunotherapy.

[27]  S. Trefely,et al.  Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47−mediated ‘don’t-eat-me’ signal , 2019, Nature Immunology.

[28]  B. Sacchetti,et al.  CAR-T cells: the long and winding road to solid tumors , 2018, Cell Death & Disease.

[29]  Zhen Gu,et al.  Macrophage-Specific in Vivo Gene Editing Using Cationic Lipid-Assisted Polymeric Nanoparticles. , 2018, ACS nano.

[30]  G. Holländer,et al.  CAR-T Cells: A Systematic Review and Mixed Methods Analysis of the Clinical Trial Landscape. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[31]  R. Levy,et al.  Axicabtagene Ciloleucel CAR T‐Cell Therapy in Refractory Large B‐Cell Lymphoma , 2017, The New England journal of medicine.

[32]  Lisa C. Wallace,et al.  Targeting Glioma Stem Cells through Combined BMI1 and EZH2 Inhibition , 2017, Nature Medicine.

[33]  David Cameron,et al.  11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial , 2017, The Lancet.

[34]  D. Reardon,et al.  Adult brainstem gliomas , 2016, Cancer.

[35]  C. You,et al.  Radiotherapy for diffuse brainstem glioma in children and young adults. , 2016, The Cochrane database of systematic reviews.

[36]  S. Rosenberg,et al.  Adoptive cell transfer as personalized immunotherapy for human cancer , 2015, Science.

[37]  R. Sigel,et al.  Photo-induced uncaging of a specific Re( i ) organometallic complex in living cells , 2014 .

[38]  Jeffrey W Pollard,et al.  Tumor-associated macrophages: from mechanisms to therapy. , 2014, Immunity.

[39]  P. Allavena,et al.  Tumor-associated macrophages: functional diversity, clinical significance, and open questions , 2013, Seminars in Immunopathology.

[40]  R. Barker,et al.  Intracellular SERS Nanoprobes For Distinction Of Different Neuronal Cell Types , 2013, Nano letters.

[41]  M. Chamberlain,et al.  Brainstem Glioma: A Review , 2013, Current Neurology and Neuroscience Reports.

[42]  Yuquan Wei,et al.  Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature , 2012, PloS one.

[43]  T. MacDonald,et al.  Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem glioma. , 2010, Cancer research.

[44]  J. Julien,et al.  Increased glioma growth in mice depleted of macrophages. , 2007, Cancer research.

[45]  T. Fleming,et al.  Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. , 2001, The New England journal of medicine.